reports
Ligand Pharmaceuticals Inc: 1 director
A director at Ligand Pharmaceuticals Inc sold 1,804 shares at 188.310USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance Introduces 2026 full year revenue guidance of $245 million to $285 million, an approximately 15% increase in core revenue growth over 2025, royalty revenue of $200 to $225 million, a 40% increase over 20251, and core adjusted earnings per diluted share of $8.00 to $9.002Increases 5-year royalty receipt outlook driven by Filspari, Ohtuvayre, and Zelsuvmi; expects to meet or exceed 23% compound annual growth rate$1 billion in deployable capital expected to drive long-term royalty revenue growth JUPITER, Fla., Dec. 09, 2025 (GLOBE ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ATNI ATN INTERNATIONAL INC.
PAHC PHIBRO ANIMAL HEALTH CORPORATION CLASS A
LGND LIGAND PHARMACEUTICALS INCORPORATED
PLNT PLANET FITNESS INC. CLASS A
HOO HERBALIFE NUTRITION LTD.
COLL COLLEGIUM PHARMACEUTICAL INC.
AMBA AMBARELLA INC.
SKY SKYLINE CHAMPION CORPORATION
NYT NEW YORK TIMES COMPANY CLASS A
DLX DELIGNIT AG
MTSI MACOM TECHNOLOGY SOLUTIONS HOLDINGS INC.
NOMDN NOMAD FOODS LTD.
LILA LIBERTY LATIN AMERICA A
DUBA DRDGOLD LTD. ADS
BW BABCOCK & WILCOX ENTERPRISES
SITM SITIME
LZ LEGALZOOM.COM INC
DERM JOURNEY MEDICAL CORP
COHR COHERENT CORP
GPCR STRUCTURE THERAPEUTICS
SBGI SINCLAIR INC
FBYD FALCONS BEYOND GLOBAL INC
MRX MAREX GROUP PLC
LB LANDBRIDGE COMPANY LLC
ORKA ORUKA THERAPEUTICS INC
ECG_w EVERUS CONSTRUCTION GROUP INC.
BKTI BK TECHNOLOGIES CORP
RAL RALLIANT CORP
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidanc...
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance Third quarter performance driven by strong portfolio royalty revenue growth of 47% 2025 full year revenue guidance increased to $225 million - $235 million (previously $200 million - $225 million) and adjusted earnings per diluted share1 increased to $7.40 - $7.65 (previously $6.70 - $7.00) Conference call begins at 8:30 a.m. Eastern Time today JUPITER, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and nine months ended Sept...
Carriage Services Announces Strong Third Quarter Results and Confirms ...
Carriage Services Announces Strong Third Quarter Results and Confirms the Midpoint of the 2025 Outlook Conference call on Thursday, November 6, 2025 at 8:00 a.m. Central Time HOUSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced its financial results for the third quarter ended September 30, 2025. Company Highlights: Total revenue grew 2.0% over the prior year quarter, driven by increased operating revenue of 5.2% primarily as a result of 21.4% growth in cemetery preneed sales;Cemetery operating revenue increased 12.6% over the prior year quar...
Ligand to Participate in November Investor Conferences
Ligand to Participate in November Investor Conferences JUPITER, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor conferences: UBS Global Healthcare Conference (Palm Beach Gardens): Management will participate in one-on-one meetings on November 10, 2025.Stifel 2025 Healthcare Conference (New York): Management will participate in a fireside chat on November 12, 2025 at 8:40 a.m. ET. Southwest IDEAS 20...
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2...
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025 JUPITER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. The company will hold a conference call beginning at 8:30 a.m. ET to discuss the results and provide a general business update. Conference Call and Webcast Information Date:Thursday, November 6, 2025 Time:8:30 AM Eastern Time Conference Call:(800) 715-9871 (U.S. & Canada)(646) 307-1963 (International)Conference I...
Carriage Services Announces 2025 Third Quarter Earnings Release and Co...
Carriage Services Announces 2025 Third Quarter Earnings Release and Conference Call Schedule HOUSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced plans to release 2025 third quarter results on Wednesday, November 5, 2025, after the market closes. In conjunction with the release, Carriage Services has scheduled a conference call, which will be broadcast live via webcast on Thursday, November 6, 2025, at 8:00 a.m. Central Time. What:Carriage Services Third Quarter 2025 Earnings Conference CallWhen:Thursday, November 6, 2025 – 8:00 a.m. Central TimeH...
Ligand to Host Investor Day on December 9, 2025
Ligand to Host Investor Day on December 9, 2025 JUPITER, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its annual Investor Day will take place in New York City on Tuesday, December 9, 2025 from 10:30 a.m. to 12:00 p.m. Eastern Time at The Harvard Club. The event will include presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of the Ligand senior management team. Presentations will highlight the company’s strategy, investment activity, royalty portfolio, and long-term financial outlook. Scott Ples...
Carriage Services Declares Quarterly Cash Dividend
Carriage Services Declares Quarterly Cash Dividend HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced that its Board of Directors on October 15, 2025, declared a quarterly dividend of 11.25¢ per share payable on December 1, 2025, to common share record holders as of November 3, 2025. Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United States. Carriage operates 160 funeral homes in 24 states and 28 cemeteries in 9 states. It is dedicated to delivering premier experiences through innovation, par...
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an...
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients Second-generation delivery device offers cost-effective alternative to hospital care benefiting patients, providers, and payors Lasix ONYU is the 17th Captisol-enabled™ approved product JUPITER, Fla., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner SQ Innovation Inc. has received approval from the U.S. Food and Drug Administration (FDA) for Lasix® ONYU (furosemide injection), a novel drug-device...
Carriage Services Announces the Acquisition of Faith Chapel Funeral Ho...
Carriage Services Announces the Acquisition of Faith Chapel Funeral Homes & Crematory in Pensacola, Florida HOUSTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Carriage Services, Inc. ("Carriage" or "Carriage Services") is pleased to announce that it has acquired substantially all the assets of Faith Chapel Funeral Homes & Crematory (collectively, "Faith Chapel"), consisting of two funeral homes and a crematory, located in the Pensacola, Florida market. Mike Atwood, CEO and President of Faith Chapel, stated, “Faith Chapel has served the Pensacola community for sixty years, and our family has bee...
Veritex Holdings Inc: 1 director
A director at Veritex Holdings Inc sold 2,203 shares at 34.352USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Carriage Services Announces the Acquisition of Osceola Memory Gardens,...
Carriage Services Announces the Acquisition of Osceola Memory Gardens, Cemetery, Funeral Homes & Crematory; Porta Coeli Funeral Home & Crematory; Fisk Funeral Home & Crematory; Funeraria Borinquen; and Cremation Care Providers of Central Florida HOUSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) ("Carriage" or "Carriage Services") is pleased to announce that it has acquired substantially all the assets of Osceola Memory Gardens, Cemetery, Funeral Homes & Crematory; Porta Coeli Funeral Home & Crematory; Fisk Funeral Home & Crematory; Funeraria Borinquen; and Cr...
Veritex Holdings, Inc. Declares Cash Dividend on Common Stock
Veritex Holdings, Inc. Declares Cash Dividend on Common Stock DALLAS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or the “Company”), the parent holding company for Veritex Community Bank, today announced the declaration of a cash dividend of $0.22 per share on its outstanding common stock. The dividend will be paid on or after September 30, 2025 to shareholders of record as of September 16, 2025. About Veritex Holdings, Inc. Headquartered in Dallas, Texas, Veritex is a bank holding company that conducts banking activities through its wholly-owned...
Cannae Holdings Inc: 1 director
A director at Cannae Holdings Inc sold 133,333 shares at 18.590USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Carriage Services Inc: 1 director
A director at Carriage Services Inc sold 13,027 shares at 44.361USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Moody's Ratings affirms Carriage Services' B2 CFR and revises outlook ...
Moody's Ratings (Moody's) affirmed Carriage Services, Inc. (Carriage) B2 Corporate Family Rating (CFR) and B2-PD Probability of Default Rating (PDR). We also affirmed the company's B3 senior unsecured rating. The Speculative Grade Liquidity rating (SGL) is upgraded to SGL-2 from SGL-3. We also revis...
Ligand to Participate in September Investor Conferences
Ligand to Participate in September Investor Conferences JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor conferences: Citi 20th Annual BioPharma Conference (Boston): Management will participate in a fireside chat on September 3, 2025 at 11:15 a.m. ET. H.C. Wainwright 27th Annual Global Investment Conference (New York): Management will present on September 9, 2025 at 1:00 p.m. ET. Ligand ma...
Ligand Announces Closing of Convertible Senior Notes Offering
Ligand Announces Closing of Convertible Senior Notes Offering JUPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today that it completed its previously announced offering (the “offering”) of 0.75% convertible senior notes due 2030 (the “notes”). The aggregate principal amount of the notes sold in the offering was $460.0 million, which includes the purchase of an additional $60.0 million aggregate principal amount of notes by the initial purchasers pursuant to the full exercise of the initial purchasers’ option to purcha...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.